SSSibu P. Saha

Sibu P. Saha

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sibu P. Saha has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Daniel L. Davenport

    Department of Surgery, Division of Cardiothoracic Surgery, University of Kentucky College of Medicine, Lexington, Kentucky

    2 shared publications
  • Hong Shen Lu

    Saha Cardiovascular Research Center, Department of Physiology, University of Kentucky, Lexington (H.S.L.).

    2 shared publications
  • Krishna Subhash Vyas

    Private Practice; Plastic Surgery, Manhattan Eye, Ear and Throat Hospital and Lenox Hill Hospital, Northwell Health, New York, NY; Division of Plastic and Reconstructive Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Division of Plastic Surgery, Mayo Clinic, Rochester, MN

    2 shared publications
  • Shayan Mohammadmoradi

    Department of Molecular and Cellular Biochemistry, College of Medicine, University of Kentucky, Lexington, KY

    2 shared publications
  • Alan Daugherty

    Saha Cardiovascular Research Center, University of Kentucky , Lexington, KY, USA Department of Pharmacology and Nutritional Sciences, University of Kentucky , Lexington, KY, USA Department of Physiology, University of Kentucky , Lexington, KY, USA

    1 shared publication
  • Alan Daugherty

    University of Kentucky

    1 shared publication

Latest Publications

  • Open Access

    Bitter Melon (Momordica charantia L.) Supplementation Has No Effect on Hypercholesterolemia and Atherosclerosis in Mice

    by Shayan Mohammadmoradi, Deborah A Howatt, Hong S Lu, Alan Daugherty, Sibu P Saha

    Bitter melon (BM; Momordica charantia L.) has been reported to ameliorate diet-induced obesity and dyslipidemia. However, the effects of BM on atherosclerosis have not been determined. This study investigated the effects of BM diet-induced atherosclerosis in LDL receptor–deficient mice. A total of 30 female mice (aged 6–8 wk) were fed a saturated fat–enriched diet. In group 1 (n = 10), mice were fed this diet alone, whereas mice in groups 2 and 3 (n = 10/group) were fed the diet supplemented with BM either 0.1% or 1% by weight. After 12 wk, body weight, plasma cholesterol, and atherosclerotic plaque areas were analyzed. No significant differences in body weight and plasma cholesterol concentrations were observed among the groups. Also, BM supplementation did not affect atherosclerosis development. In conclusion, dietary BM has no effect on plasma cholesterol concentration and atherogenesis in hypercholesterolemic mice.


  • Open Access

    Bitter Melon ( Momordica Charantia ) Supplementation Has no Effect on Hypercholesterolemia and Atherosclerosis in Mice

    by Shayan Mohammadmoradi, Deborah A. Howatt, Hong S. Lu, Alan Daugherty, Sibu P. Saha

    Momordica Charantia, commonly known as bitter melon, has been reported to ameliorate diet-induced obesity and dyslipidemia. However, the effects of M. Charantia on atherosclerosis have not been determined. This study investigated the effects of M. Charantia on diet-induced atherosclerosis in LDL receptor deficient mice. Female mice (6-8 weeks old) were fed a saturated fat-enriched diet. In group 1, mice were fed this diet alone, while mice in groups 2 and 3 were fed the diet supplemented with M. Charantia either 0.1% or 1% by weight, for 12 weeks. No significant differences in body weights were observed among the 3 groups. There were also no significant differences in plasma cholesterol concentrations among the 3 groups. To determine the effects on atherosclerosis, lesion areas were measured on aortic intima by an en face technique. Neither dose of M. Charantia supplementation changed atherosclerosis development.

  • Contemporary Management of Pulmonary Arteriovenous Malformations

    by Nicholas Rauh, John Gurley, Sibu Saha

    Pulmonary arteriovenous malformations (PAVMs) are atypical vascular structures involving a direct connection between the pulmonary arterial and venous circulations. While PAVMs are a relatively uncommon disorder, unmanaged cases are at risk for the development of serious complications including embolization and infection. Since their first description in 1897, PAVMs have been identified and treated in a variety of ways. Advancements in diagnostic methods and operative techniques have allowed for more effective treatment of the disease. Most recently, the use of vascular plug transcatheter embolization has been described as an effective therapeutic procedure in the management of PAVMs. In this report, we present our experience with nine cases of PAVMs treated at the University of Kentucky, including special consideration of an exemplary case that illustrates the typical course of treatment for the disease.


  • Outcomes of Carotid Endarterectomy with Primary Closure

    by Ivy Cheng, Krishna S. Vyas, Santhosh Velaga, Daniel L. Davenport, Sibu P. Saha

    Carotid endarterectomy (CEA) reduces the risk of stroke in patients with internal carotid artery stenosis, although the optimal surgical technique is debated. The literature suggests that patch angioplasty reduces complication risk, although primary closure shortens cross-clamp time and eliminates complications associated with grafts.The objective of this study was to assess the complication rate after CEA with primary closure.Retrospective review of 240 consecutive patients between 2002 and 2010. Of these patients, 70% returned for follow-up visits for at least 2 or more years.Primary closure was used in all patients. The average cross-clamp time was 18 minutes. Complications in the immediate postoperative period within 30 days were as follows: stroke (n = 3; 1.1%), transient ischemic attack (TIA; n = 4; 1.5%), myocardial infarction (MI; n = 3; 1.1%), and death (n = 1; 0.4%). Short-term follow-up revealed eight patients who were found to have significant restenosis (>80%) by carotid duplex imaging. Two to ten year postoperative complication rates were as follows: stroke (n = 7; 4.2%), TIA (n = 7; 4.2%), amaurosis fugax (n = 1; 0.6%), MI (n = 8; 4.8%), and death (n = 28; 17%). Mortality was due to stroke or heart attack (n = 2; 1.2%), cancer (n = 7; 4.2%), and unknown causes (n = 19; 11%).This study presents our experience with complications after primary closure after CEA. In our experience, CEA is a safe and effective surgical means of preventing stroke in the short term. Well-designed prospective studies are needed to confirm specific patient characteristics in which primary closure and patch angioplasty are indicated.


  • Trends and practice patterns in the management of thoracic empyema

    by Krishna S Vyas, Sibu P Saha, Daniel L Davenport, Victor A Ferraris, Joseph B Zwischenberger

    This study explored the modern treatment of thoracic empyema. We evaluated outcomes of various operative approaches in both academic and nonacademic institutions. We queried the Society of Thoracic Surgeons National Database for patients undergoing thoracic procedures with a primary diagnosis of empyema between 2009 and 2011. We compared treatment outcomes of patients having procedures at academic (n = 1101, 28.3%) and nonacademic (n = 2790, 71.7%) medical centers. Empyema treatments recorded in the database included tube thoracostomy (n = 325, 8.4%), video-assisted thoracic surgery (n = 1992, 51.2%), and thoracotomy (n = 1574, 40.5%). Academic centers had higher rates of treatment by thoracostomy (13.8% vs. 6.2%), similar treatment rates of video-assisted thoracic surgery (49.9% vs. 51.7%), and lower rates of thoracotomy (36.3% vs. 42.1%) compared to nonacademic centers (p < 0.001). Academic centers treated almost twice as many complicated empyemas with fistulas (11.4% vs. 6.5%, p < 0.001). Postoperative length of stay was higher in the academic centers (interquartile range 5–13 vs. 4–11 days, p = 0.001), while mechanical ventilation >48 h was more frequent in the nonacademic centers (7.6% vs. 4.4%, p = 0.013). Surgeons in both academic and nonacademic centers use selective surgical approaches for treatment of thoracic empyema, depending on the clinical condition of the patient, with fairly equivalent results across all procedure types.


  • Mediastinoscopy

    by Krishna S. Vyas, Daniel L. Davenport, Victor A. Ferraris, Sibu P. Saha

    Objectives: Historically, mediastinoscopy has been the gold standard for the staging of lung cancer. A practice gap exists as the result of a variation in knowledge concerning current trends and practice patterns of mediastinoscopy usage. In addition, there are regional variations in practice-based learning and patient care. Lessons learned during surgeries performed on patients with lung cancer...


    • 1 March 2010
      • Vol. 2  (1) , 4-5

    CT signs of solitary fibrous tumors of the pleura.

    by Sibu P Saha